20 August 2024
13 August 2024
READ MOREPurdue and Akston Biosciences Sign Partnership Agreement for Dog Cancer Drug Development
30 July 2024
READ MOREDechra Purchases Veterinary Insulin Programs from Akston Biosciences
17 June 2024
READ MOREDr. Linda Rhodes Joins Akston Biosciences’ Board of Directors
11 March 2024
READ MOREAkston Biosciences’ AKS-107 Study Published in Frontiers in Immunology, Displaying Ambifect® Platform’s Versatility
26 February 2024
READ MOREAkston Biosciences’ AKS-452 Vaccine Study Published in Nature, Showcasing Ambifect® Platform’s Versatility
31 August 2023
READ MOREAkston Biosciences Receives 2023 Most Innovative Award at Animal Health Summit
28 August 2023
READ MOREAkston Biosciences CEO to Present at the 2023 Animal Health Summit in Kansas City
17 August 2023
READ MOREAkston Biosciences to Focus on Strong Animal Health Pipeline
9 March 2023